Mori Seijiro
Tokyo Metropolitan Geriatric Hospital.
Clin Calcium. 2010 Feb;20(2):182-8.
As compared with postmenopausal osteoporosis, male osteoporosis is not common ; approximately one third of the female osteoporosis in frequency, but is an increasingly recognized problem with associated fracture morbidity and mortality. As opposed to postmenopausal women, reduced bone formation is the predominant mechanism of age-related bone loss in men. Although both serum free testosterone and free estradiol levels decline with age in men, it has been proved that estrogen plays an important role in maintaining bone mass in men. For the most common osteoporosis therapies (bisphosphonates and PTH) the effects in men appear very similar to those in women.
与绝经后骨质疏松症相比,男性骨质疏松症并不常见;其发病频率约为女性骨质疏松症的三分之一,但却是一个日益受到关注的问题,与骨折发病率和死亡率相关。与绝经后女性不同,骨形成减少是男性年龄相关性骨质流失的主要机制。尽管男性血清游离睾酮和游离雌二醇水平均随年龄下降,但已证实雌激素在维持男性骨量方面起着重要作用。对于最常见的骨质疏松症治疗方法(双膦酸盐和甲状旁腺激素),其对男性的效果似乎与对女性的效果非常相似。